Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D DeBoer

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|March 12, 2011
What can anorexia nervosa teach us about appetite regulation?Mark D DeBoer
Current Pharmaceutical Design|May 29, 2012
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanismMark D DeBoer
Molecular and Cellular Endocrinology|March 1, 2011
Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?Mark D DeBoer
Current Cardiovascular Risk Reports|March 8, 2011
Underdiagnosis of Metabolic Syndrome in Non-Hispanic Black Adolescents: A Call for Ethnic-Specific CriteriaMark D Deboer
Nutrients|August 7, 2019
Assessing and Managing the Metabolic Syndrome in Children and AdolescentsMark D DeBoer
Current Opinion in Clinical Nutrition and Metabolic Care|June 15, 2007
Melanocortin interventions in cachexia: how soon from bench to bedside?Mark D DeBoer
International Journal of Peptides|August 17, 2011
Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerationsMark D Deboer
Expert Review of Endocrinology & Metabolism|June 7, 2011
Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting interventionMark D Deboer
Nutrition (Burbank, Los Angeles County, Calif.)|October 2, 2012
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventionsMark D DeBoer
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 26, 2025
The Rise and Rise of Type 1 and Type 2 Diabetes in YouthMark D DeBoer
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Nutrition (Burbank, Los Angeles County, Calif.)|March 12, 2011
What can anorexia nervosa teach us about appetite regulation?Mark D DeBoer
Current Pharmaceutical Design|May 29, 2012
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanismMark D DeBoer
Molecular and Cellular Endocrinology|March 1, 2011
Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?Mark D DeBoer
Current Cardiovascular Risk Reports|March 8, 2011
Underdiagnosis of Metabolic Syndrome in Non-Hispanic Black Adolescents: A Call for Ethnic-Specific CriteriaMark D Deboer
Nutrients|August 7, 2019
Assessing and Managing the Metabolic Syndrome in Children and AdolescentsMark D DeBoer
Current Opinion in Clinical Nutrition and Metabolic Care|June 15, 2007
Melanocortin interventions in cachexia: how soon from bench to bedside?Mark D DeBoer
International Journal of Peptides|August 17, 2011
Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerationsMark D Deboer
Expert Review of Endocrinology & Metabolism|June 7, 2011
Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting interventionMark D Deboer
Nutrition (Burbank, Los Angeles County, Calif.)|October 2, 2012
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventionsMark D DeBoer
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 26, 2025
The Rise and Rise of Type 1 and Type 2 Diabetes in YouthMark D DeBoer
Pageof 17